Publicaciones científicas

Búsqueda avanzada

Mieloma múltiple y nuevos fármacos

Año: 2011
- Long-term prognostic significance of response in multiple myeloma after stem cell transplantation
  Joaquin Martinez-Lopez; Joan Blade; María Victoria Mateos ; Carlos Grande; Adrian Alegre; Jose Garcia-Larana; Anna Sureda; Javier de la Rubia; Eulogio Conde; Rafael Martinez; Felipe de Arriba; Maria C. Viguria; Joan Besalduch; Rafael Cabrera; Jose D. Gonzalez-San Miguel; Jose Luis Guzman-Zamudio; Ma Carmen Gomez del Castillo; Jose Ma Moraleda; Juan C. Garcia-Ruiz; Jesús Fernando San Miguel Izquierdo; Juan Jose Lahuerta; GEM Cooperative Study Grp; PETHEMA Cooperative Study Grp
  Blood 118: 529-534. FI: 10,558(Q1)
- Maintenance Therapy with Bortezomib Plus Thalidomide (VT) or Bortezomib Plus Prednisone (VP) In Elderly Myeloma Patients Included In the GEM2005MAS65 Spanish Randomized Trial
  María Victoria Mateos ; Albert Oriol; Ana-Isabel Teruel; Enrique Bengoechea; Montse Perez; Javier Lopez; Joaquin Diaz-Mediavilla; Jose Mariano Hernandez; Felipe de Arriba; Yolanda Gonzalez; Joan Blade; Juan Jose Lahuerta; Jesús Fernando San Miguel Izquierdo
  Blood 118: 222-0. FI: 10,558(Q1)
- Multidimensional Flow Cytometric (MFC) Analysis of the Immune System of Multiple Myeloma (MM) Patients Achieving Long Term Disease Control
  Roberto J. Pessoa Magalhaes; María Belén Vidriales Vicente; Bruno David Lourenço Paiva; María Victoria Mateos ; Norma Carmen Gutiérrez Gutiérrez; Ramón García Sanz ; Juan Francisco Blanco Blanco; Jose Hernandez; Natalia de las Heras; Joaquin Martinez; Elaine Sobral Costa; Angelo Maiolino; M. Nucci; Javier De La Rubia; Juan-Jose Lahuerta; JOSE ALBERTO ORFAO DE MATOS CORREIA E VALE; Jesús Fernando San Miguel Izquierdo
  Blood 118: 367-368. FI: 10,558(Q1)
- Multiple Myeloma Treatment Strategies with Novel Agents in 2011: A European Perspective
  Heinz Ludwig; Meral Beksac; Joan Blade; Jamie Cavenagh; Michele Cavo; Michel Delforge; Meletios Dimopoulos; Johannes Drach; Hermann Einsele; Thierry Facon; Hartmut Goldschmidt; Jean-Luc Harousseau; Urs Hess; Martin Kropff; Fernando Leal da Costa; Vernon Louw; Hila Magen-Nativ; Larisa Mendeleeva; Hareth Nahi; Torben Plesner; Jesús Fernando San Miguel Izquierdo; Pieter Sonneveld; Miklos Udvardy; Pia Sondergeld; Antonio Palumbo
  Oncologist 16: 388-403. FI: 5,826(Q1)
- Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
  M. A. Dimopoulos; A. Palumbo; M. Attal; M. Beksac; F. E. Davies; M. Delforge; H. Einsele; R. Hajek; J-L Harousseau; F. Leal da Costa; H. Ludwig; U-H Mellqvist; G. J. Morgan; Jesús Fernando San Miguel Izquierdo; S. Zweegman; P. Sonneveld; European Myeloma Network
  Leukemia 25: 749-760. FI: 8,966(Q1)
- Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance
  María Victoria Mateos ; Norma Carmen Gutiérrez Gutiérrez; Maria-Luisa Martin-Ramos; Bruno David Lourenço Paiva; Maria-Angeles Montalban; Albert Oriol; Joaquin Martinez-Lopez; Ana-Isabel Teruel; Enrique Bengoechea; Alejandro Martín García Sancho; Joaquin Diaz-Mediavilla; Felipe de Arriba; Luis Palomera; Jose-Mariano Hernandez; Anna Sureda; Joan Bargay; Francisco-Javier Penalver; Josep-Maria Ribera; Maria-Luisa Martin-Mateos; Manuela Fernandez; Ramón García Sanz ; María Belén Vidriales Vicente; Joan Blade; Juan-Jose Lahuerta; Jesús Fernando San Miguel Izquierdo
  Blood 118: 4547-4553. FI: 10,558(Q1)
- Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
  Antonio Palumbo; Sara Bringhen; Heinz Ludwig; Meletios A. Dimopoulos; Joan Blade; María Victoria Mateos ; Laura Rosinol; Mario Boccadoro; Michele Cavo; Henk Lokhorst; Sonja Zweegman; Evangelos Terpos; Faith Davies; Christoph Driessen; Peter Gimsing; Martin Gramatzki; Roman Hajek; Hans E. Johnsen; Fernando Leal Da Costa; Orhan Sezer; Andrew Spencer; Meral Beksac; Gareth Morgan; Hermann Einsele; Jesús Fernando San Miguel Izquierdo; Pieter Sonneveld
  Blood 118: 4519-4529. FI: 10,558(Q1)
- Post-Treatment Bone Marrow Residual Disease > 5% by Flow Cytometry Is Highly Predictive of Short Progression-Free and Overall Survival in Patients With Waldenstrom's Macroglobulinemia
  Ramón García Sanz ; Enrique M Ocio San Miguel; D. del Carpio; A. Caballero; R. J. P. Magalhaes; J. Alonso; Lucía López Anglada Fernández; T. Villaescusa; Noemí Puig Morón; J. M. Hernandez; J. Fernandez-Calvo; A. Aguilar; A. Martin; R. Lopez; Bruno David Lourenço Paiva; JOSE ALBERTO ORFAO DE MATOS CORREIA E VALE; María Belén Vidriales Vicente; Jesús Fernando San Miguel Izquierdo
  Clinical Lymphoma Myeloma & Leukemia 11: 168-171. FI: 1,988(Q3)
- Practical management of adverse events in multiple myeloma: Can therapy be attenuated in older patients?
  Antonio Palumbo; María Victoria Mateos ; Sara Bringhen; Jesús Fernando San Miguel Izquierdo
  Blood Reviews 25: 181-191. FI: 5,619(Q1)
- Reversibility of the Resistance to Lenalidomide and Pomalidomide and Absence of Cross-Resistance in a Murine Model of MM
  Enrique M Ocio San Miguel; Diego Fernández Lázaro; Laura San Segundo Payo; LORENA González MENDEZ; Mª Montserrat Martín Sánchez; Mercedes Garayoa Berrueta; Teresa Paíno Gómez; Antonio García Gómez; Norma Carmen Gutiérrez Gutiérrez; Manuel Delgado Criado; Juan Carlos Montero González; Nuria Quintana; Jose Luis Garcia; Atanasio Pandiella ; Jesús Fernando San Miguel Izquierdo
  Blood 118: 65-0. FI: 10,558(Q1)

204 resultados

Páginas: << < 5 6 7 8 9 > >>

NoticiasNoticias
Zona del InvestigadorZona del Investigador